Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction

Xu, DF; Chen, QL; Liu, YL; Wen, XQ

Xu, DF (reprint author), Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Changzhou 213164, Jiangsu, Peoples R China.; Wen, XQ (reprint author), Southern Med Univ, Shenzhen Hosp, Dept Urol, Shenzhen 518100, Guangdong, Peoples R China.

ONCOTARGET, 2017; 8 (62): 105561

Abstract

Background: Androgen receptor (AR) plays a critical role in prostate cancer (PCa) development and progression. Androgen deprivation therapy with antia......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索